Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder
J Bradwejn, D Koszycki
Psychiatry Research
|
April 5, 2001
Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorder
D Koszycki, J Bradwejn
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
November 21, 2001
Cholecystokinin and panic disorder: past and future clinical research strategies
J Bradwejn, D Koszycki
The American Journal of Psychiatry
|
February 1, 1994
Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients
J Bradwejn, D Koszycki
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 1, 1990
Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder
J Bradwejn, D Koszycki, G Meterissian
Archives of General Psychiatry
|
July 1, 1991
Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings
J Bradwejn, D Koszycki, C Shriqui
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 1, 1991
Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers
D Koszycki, J Bradwejn, M Bourin
L'Encephale
|
September 1, 1991
[Is cholecystokinin a biological support in panic attacks?]
M Bourin, J Bradwejn, D Koszycki
Journal of Psychiatry & Neuroscience : JPN
|
July 1, 1991
Dose ranging study of the effects of cholecystokinin in healthy volunteers
J Bradwejn, D Koszycki, M Bourin
Peptides
|
August 13, 1998
Decrease in short-term memory function induced by CCK-4 in healthy volunteers
J Shlik, D Koszycki, J Bradwejn
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder
J Bradwejn, D Koszycki
Psychiatry Research
|
April 5, 2001
Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorder
D Koszycki, J Bradwejn
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
November 21, 2001
Cholecystokinin and panic disorder: past and future clinical research strategies
J Bradwejn, D Koszycki
The American Journal of Psychiatry
|
February 1, 1994
Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients
J Bradwejn, D Koszycki
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 1, 1990
Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder
J Bradwejn, D Koszycki, G Meterissian
Archives of General Psychiatry
|
July 1, 1991
Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings
J Bradwejn, D Koszycki, C Shriqui
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 1, 1991
Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers
D Koszycki, J Bradwejn, M Bourin
L'Encephale
|
September 1, 1991
[Is cholecystokinin a biological support in panic attacks?]
M Bourin, J Bradwejn, D Koszycki
Journal of Psychiatry & Neuroscience : JPN
|
July 1, 1991
Dose ranging study of the effects of cholecystokinin in healthy volunteers
J Bradwejn, D Koszycki, M Bourin
Peptides
|
August 13, 1998
Decrease in short-term memory function induced by CCK-4 in healthy volunteers
J Shlik, D Koszycki, J Bradwejn
Page
of 4